WEST MICHAEL D 4
4 · AgeX Therapeutics, Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
WEST MICHAEL D
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2022-03-11$0.69/sh−1,281$887→ 40,415 total - Exercise/Conversion
Common Stock, $0.0001 par value
2022-03-11+3,125→ 41,696 total - Exercise/Conversion
Restricted Stock Units
2022-03-11−3,125→ 12,500 totalExercise: $0.00→ Common Stock (3,125 underlying)
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Restricted Stock Units vested on March 11, 2022.